Search research articles
Contact Us
Filters
Showing results (101-110 of 254) with videos related to
Page
of 26
Sort By:
The Pediatric Infectious Disease Journal
|
December 8, 2023
Pan-valvulitis in Children With Kawasaki Disease: A Case Report and Review of the Literature
Pelayo Leon-Jimenez, Maria Lorenzo-Martin, Cristiana Tomatis-Souverbielle, et al.
The Pediatric Infectious Disease Journal
|
August 6, 2004
Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection
Xavier Sáez-Llorens, María T Moreno, Octavio Ramilo, et al.
Vaccine
|
August 6, 2017
Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns
Lisa M Christian, Chloe Beverly, Amanda M Mitchell, et al.
The Journal of Infectious Diseases
|
November 13, 2018
Viral Load Dynamics and Clinical Disease Severity in Infants With Respiratory Syncytial Virus Infection
Cristina Garcia-Mauriño, Melissa Moore-Clingenpeel, Jessica Thomas, et al.
The Pediatric Infectious Disease Journal
|
March 15, 2016
Diagnosis of Pediatric Acute Adenovirus Infections: Is a Positive PCR Sufficient?
Eunkyung Song, Huanyu Wang, Adriana E Kajon, et al.
Pediatric Pulmonology
|
July 1, 2022
Long-term pulmonary sequelae in adolescents post-SARS-CoV-2 infection
Sabrina Palacios, Katelyn Krivchenia, Mariah Eisner, et al.
Immunity
|
June 14, 2024
Longitudinal humoral analysis in RSV-infected infants identifies pre-existing RSV strain-specific G and evolving cross-reactive F antibodies
Nadège Nziza, Wonyeong Jung, Maanasa Mendu, et al.
Practical Laboratory Medicine
|
May 8, 2024
Correlation between locally versus centrally processed serum procalcitonin during emergency department research evaluation of febrile infants aged 0-60 days
Cosby G Arnold, Prashant Mahajan, Russell K Banks, et al.
Emerging Infectious Diseases
|
October 26, 2022
Differences in SARS-CoV-2 Clinical Manifestations and Disease Severity in Children and Adolescents by Infecting Variant
Ana Maria Quintero, Mariah Eisner, Rouba Sayegh, et al.
Virology Journal
|
October 27, 2007
Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model
Asunción Mejías, Susana Chávez-Bueno, Martin B Raynor, et al.
Page
of 26
Search research articles
Search
Showing results (101-110 of 254) with videos related to
Sort By:
Page
of 26
The Pediatric Infectious Disease Journal
|
December 8, 2023
Pan-valvulitis in Children With Kawasaki Disease: A Case Report and Review of the Literature
Pelayo Leon-Jimenez, Maria Lorenzo-Martin, Cristiana Tomatis-Souverbielle, et al.
The Pediatric Infectious Disease Journal
|
August 6, 2004
Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection
Xavier Sáez-Llorens, María T Moreno, Octavio Ramilo, et al.
Vaccine
|
August 6, 2017
Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns
Lisa M Christian, Chloe Beverly, Amanda M Mitchell, et al.
The Journal of Infectious Diseases
|
November 13, 2018
Viral Load Dynamics and Clinical Disease Severity in Infants With Respiratory Syncytial Virus Infection
Cristina Garcia-Mauriño, Melissa Moore-Clingenpeel, Jessica Thomas, et al.
The Pediatric Infectious Disease Journal
|
March 15, 2016
Diagnosis of Pediatric Acute Adenovirus Infections: Is a Positive PCR Sufficient?
Eunkyung Song, Huanyu Wang, Adriana E Kajon, et al.
Pediatric Pulmonology
|
July 1, 2022
Long-term pulmonary sequelae in adolescents post-SARS-CoV-2 infection
Sabrina Palacios, Katelyn Krivchenia, Mariah Eisner, et al.
Immunity
|
June 14, 2024
Longitudinal humoral analysis in RSV-infected infants identifies pre-existing RSV strain-specific G and evolving cross-reactive F antibodies
Nadège Nziza, Wonyeong Jung, Maanasa Mendu, et al.
Practical Laboratory Medicine
|
May 8, 2024
Correlation between locally versus centrally processed serum procalcitonin during emergency department research evaluation of febrile infants aged 0-60 days
Cosby G Arnold, Prashant Mahajan, Russell K Banks, et al.
Emerging Infectious Diseases
|
October 26, 2022
Differences in SARS-CoV-2 Clinical Manifestations and Disease Severity in Children and Adolescents by Infecting Variant
Ana Maria Quintero, Mariah Eisner, Rouba Sayegh, et al.
Virology Journal
|
October 27, 2007
Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model
Asunción Mejías, Susana Chávez-Bueno, Martin B Raynor, et al.
Page
of 26